Kelun-Biotech announces breakthrough therapy designation granted for Sacituzumab tirumotecan (Sac-TMT) in combination with Tagitanlimab in...

DESTINY-Endometrial01 phase 3 Trial of Enhertu initiated as first-line therapy in patients with HER2 expressing...

Simtra BioPharma solutions and MilliporeSigma announce strategic alliance for antibody drug conjugates drug substance and...

Medicovestor and Sanyou Biopharmaceuticals forge strategic partnership to develop first-in-class chemoimmunotherapy antibody-drug conjugates

OBI Pharma Enters ADC Collaboration with TegMine Therapeutics utilizing GlycOBI® and TegMine Enabling Technologies

SK plasma enters ADC cancer drug development with AIMEDBIO partnership